HCPLive

ADHD 
The MD Magazine ADHD condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Too Many Pills, Too Little Therapy for Youngest ADHD Kids
Half of very young children with ADHD are treated with medication rather than the behavioral modification that the American Academy of Pediatrics has recommended as first-line treatment, a CDC report finds.
A possible connection between Attention Deficit/Hyperactivity Disorder (ADHD) and a genetic malfunction in the thalamus may explain the distractibility and physical restlessness that plague children and adults with ADHD,
Persistent parental criticism appears to be among the reasons why attention deficit hyperactivity disorder (ADHD) symptoms persist with age among some children, as opposed to decreasing with age as seen with many children with ADHD.
Researchers from Massachusetts General Hospital who analyzed medical records from three healthcare systems in their state have found no evidence to indicate that prenatal exposure to antidepressants increases the risk for autism and related disorders or for ADHD.
The FDA has approved Tris Pharma's extended-release amphetamine oral suspension (Dyanavel XR) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older.
Rates of attention deficit hyperactivity disorder (ADHD) drop as elevation increases, according to findings published in the Journal of Attention Disorders.
Study results published in the July-August 2015 issue of the Journal of the American Board of Family Medicine suggest a potential association between maternal chemical intolerance and a diagnosis of attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) in their offspring.
Compared to healthy individuals, ADHD patients are 2 times more likely to die prematurely – and the risk is higher in women and girls.
In contrast to recent studies linking patients who reside in higher elevations with increased rates of depression and suicide, a new study suggests that the prevalence of attention-deficit hyperactivity disorder appears to decrease as altitude increases.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$